litlas
ログインアカウント作成

Michael R. Lassen

1989–2021 年に発表

31
論文数
24,628
被引用数
31
h 指数
31
i10 指数

被引用数

Michael R. Lassen の年別被引用数1989 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 4 件1993 年: 被引用 5 件1994 年: 被引用 4 件1995 年: 被引用 6 件1996 年: 被引用 2 件1997 年: 被引用 2 件1998 年: 被引用 12 件1999 年: 被引用 5 件2000 年: 被引用 9 件2001 年: 被引用 17 件2002 年: 被引用 44 件2003 年: 被引用 43 件2004 年: 被引用 69 件2005 年: 被引用 87 件2006 年: 被引用 80 件2007 年: 被引用 125 件2008 年: 被引用 135 件2009 年: 被引用 214 件2010 年: 被引用 289 件2011 年: 被引用 255 件2012 年: 被引用 277 件2013 年: 被引用 242 件2014 年: 被引用 168 件2015 年: 被引用 130 件2016 年: 被引用 133 件2017 年: 被引用 122 件2018 年: 被引用 81 件2019 年: 被引用 448 件2020 年: 被引用 416 件2021 年: 被引用 379 件2022 年: 被引用 269 件2023 年: 被引用 172 件2024 年: 被引用 297 件2025 年: 被引用 62 件2026 年: 被引用 1 件1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,335 件、この内訳の 22.1%カナダ: 引用元論文 547 件、この内訳の 9.1%イギリス: 引用元論文 482 件、この内訳の 8%ドイツ: 引用元論文 386 件、この内訳の 6.4%イタリア: 引用元論文 358 件、この内訳の 5.9%フランス: 引用元論文 278 件、この内訳の 4.6%オランダ: 引用元論文 278 件、この内訳の 4.6%中国: 引用元論文 195 件、この内訳の 3.2%スペイン: 引用元論文 173 件、この内訳の 2.9%スイス: 引用元論文 158 件、この内訳の 2.6%日本: 引用元論文 153 件、この内訳の 2.5%スウェーデン: 引用元論文 146 件、この内訳の 2.4%
0%22.1%その他 25.7%

機関

分野

  • Medicine93.6%
  • Health Professions1.5%
  • Biochemistry, Genetics and Molecular Biology1.4%
  • Immunology and Microbiology0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Engineering0.8%
  • その他1%

トピック

  • Venous Thromboembolism Diagnosis and Management21.7%
  • Atrial Fibrillation Management and Outcomes13.9%
  • Blood Coagulation and Thrombosis Mechanisms5.9%
  • Heparin-Induced Thrombocytopenia and Thrombosis4.1%
  • Antiplatelet Therapy and Cardiovascular Diseases3.2%
  • Central Venous Catheters and Hemodialysis2.7%
  • その他48.5%

共著者

全論文

検索で開く
  1. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients

    著者: Sam Schulman, Ulf Angerås, David Bergqvist, Bengt O. Eriksson, Michael R. Lassen, Winfield S. Fisher - Journal of Thrombosis and Haemostasis 2009 被引用: 3,759

  2. Milvexian for the Prevention of Venous Thromboembolism

    著者: Jeffrey I. Weitz, John Strony, Walter Ageno, David Gailani, Elaine M. Hylek, Michael R. Lassen, Kenneth W. Mahaffey, Ravi S. Notani, Robin Roberts, Annelise Segers, Gary E. Raskob - New England Journal of Medicine 2021 被引用: 248

  3. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty

    著者: Jeffrey I. Weitz, Rupert Bauersachs, Bastian Becker, Scott D. Berkowitz, Maria Cecília S. Freitas, Michael R. Lassen, Carola Metzig, Gary E. Raskob - JAMA 2020 被引用: 249

  4. Prevention of Venous Thromboembolism

    著者: William Geerts, Graham F. Pineo, John A. Heit, David Bergqvist, Michael R. Lassen, Clifford W. Colwell, Joel G. Ray - CHEST Journal 2004 被引用: 5,912

  5. Prevention of Venous Thromboembolism

    著者: William Geerts, David Bergqvist, Graham F. Pineo, John A. Heit, Charles Marc Samama, Michael R. Lassen, Clifford W. Colwell - CHEST Journal 2008 被引用: 3,812

  6. Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement

    著者: Michael R. Lassen, Alexander Gallus, Gary E. Raskob, Graham F. Pineo, Dalei Chen, Luz M. Ramirez - New England Journal of Medicine 2010 被引用: 775

  7. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

    著者: Michael R. Lassen, Gary E. Raskob, Alexander Gallus, Graham F. Pineo, Dalei Chen, Philip Hornick - The Lancet 2010 被引用: 777

  8. Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty

    著者: Michael R. Lassen, Walter Ageno, Lars C. Borris, Jay R. Lieberman, Nadia Rosencher, Tiemo J. Bandel, Frank Misselwitz, Alexander G.G. Turpie - New England Journal of Medicine 2008 被引用: 1,296

  9. Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

    著者: Giancarlo Agnelli, Daniel J. George, Ajay K. Kakkar, William Fisher, Michael R. Lassen, Patrick Mismetti, Patrick Mouret, Umesh Chaudhari, Francesca Lawson, Alexander G.G. Turpie - New England Journal of Medicine 2012 被引用: 533

  10. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

    著者: Alexander GG Turpie, Michael R. Lassen, Bruce L. Davidson, Kenneth A. Bauer, Michael Gent, Louis M. Kwong, Fred D. Cushner, Paul A. Lotke, Scott D. Berkowitz, Tiemo J. Bandel, Alice Benson, Frank Misselwitz, William D. Fisher - The Lancet 2009 被引用: 979

  11. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

    著者: Alexander T Cohen, Bruce L. Davidson, Alexander Gallus, Michael R. Lassen, Martin H. Prins, Witold Tomkowski, Alexander G.G. Turpie, Jan F M Egberts, Anthonie W.A. Lensing - BMJ 2006 被引用: 861

  12. Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement

    著者: Michael R. Lassen, Gary E. Raskob, Alexander Gallus, Graham F. Pineo, Dalei Chen, Ronald J. Portman - New England Journal of Medicine 2009 被引用: 694

  13. The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement

    著者: Michael R. Lassen, Bruce L. Davidson, Alexander Gallus, Graham F. Pineo, Jack Ansell, David Deitchman - Journal of Thrombosis and Haemostasis 2007 被引用: 370

  14. Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery

    著者: Kenneth A. Bauer, Bengt I. Eriksson, Michael R. Lassen, Alexander G.G. Turpie - New England Journal of Medicine 2001 被引用: 661

  15. Prevention and Treatment of Venous Thromboembolism

    著者: Aliki Nicolaides, Jawed Fareed, A.K. Kakkar, A. J. Comerota, Samuel Z. Goldhaber, Russel Hull, Kenneth A. Myers, Meyer‐Michel Samama, Jacqueline Fletcher, Evi Kalodiki, David Bergqvist, J. Bonnar, Joseph A. Caprini, C. Carter, J Conard, B Eklöf, Ismaı̈l Elalamy, Grigoris Gerotziafas, George Geroulakos, A. Giannoukas, Ian A. Greer, Maryclare Griffin, S. Kakkos, Michael R. Lassen, Gordon Lowe, Arie Markel, Paolo Prandoni, G. Raskob, Alex C. Spyropoulos, Alexander G.G. Turpie, Jeanine M. Walenga, David Warwick - Clinical and Applied Thrombosis/Hemostasis 2013 被引用: 186

  16. Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery

    著者: Bengt I. Eriksson, Kenneth A. Bauer, Michael R. Lassen, Alexander G.G. Turpie - New England Journal of Medicine 2001 被引用: 633

  17. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial

    著者: Alexander GG Turpie, Kenneth A. Bauer, Bengt I. Eriksson, Michael R. Lassen - The Lancet 2002 被引用: 534

  18. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison

    著者: Michael R. Lassen, Kenneth A. Bauer, Bengt I. Eriksson, Alexander GG Turpie - The Lancet 2002 被引用: 403

  19. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement

    著者: Gary E. Raskob, Alexander Gallus, Graham F. Pineo, Dongyang Chen, L-M. Ramirez, Richard T. Wright, Michael R. Lassen - Journal of Bone and Joint Surgery - British Volume 2012 被引用: 98

  20. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty

    著者: Michael R. Lassen, Bengt I. Eriksson, Michael Gent, Scott D. Berkowitz, Frank Misselwitz, Tiemo J. Bandel, Martin Homering, Torsten Westermeier, Ajay K. Kakkar, Alexander G.G. Turpie - Thrombosis and Haemostasis 2010 被引用: 268

  21. The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

    著者: Bengt I. Eriksson, Giancarlo Agnelli, Alexander T. Cohen, O.E. Dahl, Michael R. Lassen, Patrick Mouret, Nadia Rosencher, Peter Kälebo, Seva Panfilov, Christina Eskilson, Magnus Andersson - Journal of Thrombosis and Haemostasis 2003 被引用: 199

  22. ORIGINAL ARTICLE: Soluble Human Leukocyte Antigen‐G Isoforms in Maternal Plasma in Early and Late Pregnancy

    著者: Roberta Rizzo, Anita Sylvest Andersen, Michael R. Lassen, Helle Christina Sørensen, Thomas Bergholt, Margit Hørup Larsen, Loredana Melchiorri, Marina Stignani, Olavio R. Baricordi, Thomas Vauvert F. Hviid - American Journal of Reproductive Immunology 2009 被引用: 104

  23. Use of the Low-Molecular-Weight Heparin Reviparin to Prevent Deep-Vein Thrombosis after Leg Injury Requiring Immobilization

    著者: Michael R. Lassen, Lars C. Borris, Roumen Nakov - New England Journal of Medicine 2002 被引用: 201

  24. Prevention And Treatment Of Venous Thromboembolism : International Consensus Statement

    著者: Andrew Nicolaides, Jawed Fareed, A.K. Kakkar, A. J. Comerota, Samuel Z. Goldhaber, Russell D. Hull, K Myers, M Samama, John Fletcher, Evi Kalodiki, David Bergqvist, J. Bonnar, Joseph A. Caprini, C Carter, J Conard, B Eklöf, Ismaı̈l Elalamy, Grigoris Gerotziafas, George Geroulakos, Athanasios Giannoukas, Ian A. Greer, Maura Griffin, Stavros K. Kakkos, Michael R. Lassen, G.D.O. Lowe, Arie Markel, Paolo Prandoni, Gary E. Raskob, Alex C Spyropoulos, A. G. G. Turpie, Jeanine M. Walenga, David Warwick - International Journal of Angiology 2013 被引用: 194